Search research articles
Contact Us
Filters
Showing results (141-150 of 204) with videos related to
Page
of 21
Sort By:
The Journal of Nervous and Mental Disease
|
August 1, 1994
Depressive symptoms and the deficit syndrome of schizophrenia
B Kirkpatrick, R W Buchanan, A Breier, et al.
Biological Psychiatry
|
February 25, 1998
Hypothesis testing: is clozapine's superior efficacy dependent on moderate D2 receptor occupancy?
W T Carpenter, J M Zito, J Vitrai, et al.
Psychiatric Services (Washington, D.C.)
|
October 3, 2000
Clozapine treatment of outpatients with schizophrenia: outcome and long-term response patterns. 1993
A Breier, R W Buchanan, D Irish, et al.
Schizophrenia Bulletin
|
February 7, 2001
Risk factors for the deficit syndrome of schizophrenia
B Kirkpatrick, D Castle, R M Murray, et al.
Hospital & Community Psychiatry
|
December 1, 1993
Clozapine treatment of outpatients with schizophrenia: outcome and long-term response patterns
A Breier, R W Buchanan, D Irish, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
October 1, 1983
Risk factors in schizophrenia: season birth in Maryland, USA
A E Pulver, W Stewart, W T Carpenter, et al.
The American Journal of Psychiatry
|
February 1, 1988
Accuracy of the diagnoses of affective disorders and schizophrenia in public hospitals
A E Pulver, W T Carpenter, L Adler, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
February 1, 1977
Monoamine oxidase in chronic schizophrenia: Studies of hormonal and other factors affecting enzyme activity
D L Murphy, R Belmaker, W T Carpenter, et al.
The American Journal of Psychiatry
|
March 1, 1990
Clinical correlates of the deficit syndrome of schizophrenia
R W Buchanan, B Kirkpatrick, D W Heinrichs, et al.
The American Journal of Psychiatry
|
February 16, 1999
Diazepam treatment of early signs of exacerbation in schizophrenia
W T Carpenter, R W Buchanan, B Kirkpatrick, et al.
Page
of 21
Search research articles
Search
Showing results (141-150 of 204) with videos related to
Sort By:
Page
of 21
The Journal of Nervous and Mental Disease
|
August 1, 1994
Depressive symptoms and the deficit syndrome of schizophrenia
B Kirkpatrick, R W Buchanan, A Breier, et al.
Biological Psychiatry
|
February 25, 1998
Hypothesis testing: is clozapine's superior efficacy dependent on moderate D2 receptor occupancy?
W T Carpenter, J M Zito, J Vitrai, et al.
Psychiatric Services (Washington, D.C.)
|
October 3, 2000
Clozapine treatment of outpatients with schizophrenia: outcome and long-term response patterns. 1993
A Breier, R W Buchanan, D Irish, et al.
Schizophrenia Bulletin
|
February 7, 2001
Risk factors for the deficit syndrome of schizophrenia
B Kirkpatrick, D Castle, R M Murray, et al.
Hospital & Community Psychiatry
|
December 1, 1993
Clozapine treatment of outpatients with schizophrenia: outcome and long-term response patterns
A Breier, R W Buchanan, D Irish, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
October 1, 1983
Risk factors in schizophrenia: season birth in Maryland, USA
A E Pulver, W Stewart, W T Carpenter, et al.
The American Journal of Psychiatry
|
February 1, 1988
Accuracy of the diagnoses of affective disorders and schizophrenia in public hospitals
A E Pulver, W T Carpenter, L Adler, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
February 1, 1977
Monoamine oxidase in chronic schizophrenia: Studies of hormonal and other factors affecting enzyme activity
D L Murphy, R Belmaker, W T Carpenter, et al.
The American Journal of Psychiatry
|
March 1, 1990
Clinical correlates of the deficit syndrome of schizophrenia
R W Buchanan, B Kirkpatrick, D W Heinrichs, et al.
The American Journal of Psychiatry
|
February 16, 1999
Diazepam treatment of early signs of exacerbation in schizophrenia
W T Carpenter, R W Buchanan, B Kirkpatrick, et al.
Page
of 21